Swiss drug maker reported first-quarter profits beating estimates with operating income of $3.55 billion. Photograph: Reuters.

Novartis, the world’s biggest drugmaker by sales, reported first-quarter profits that beat analysts’ estimates as the company begins to benefit from a(...)

Nestle products. Photograph: Bryan O’Brien/Irish Times

Nestle, the world’s biggest food maker, reported first-quarter revenue growth that exceeded analyst estimates as price increases offset weak sales of (...)

UCD Smurfit School staff Dr Virginia Stewart, Professor Ciarán Ó hÓgartaigh,  Dr Virpi Turkulainen, Dr Julie Byrne, Dr Roisin Vize and Dr Jury Gualandris. Picture Jason Clarke Photography.

Trinity College has appointed a chief operating officer. Geraldine Ruane, who filled the role on an interim basis since the start of 2014, has been co(...)

Bristol-Myers Squibb, Sanofi and Novartis have the three top new drugs set to reach the market in 2015, among 11 products each with $1 billion-plus sa(...)

AstraZeneca may have a second chronic obstructive pulmonary disease treatmentan after a study showed an experimental combination of lung drugs improved breathing function. Photograph: Jason Alden/Bloomberg

AstraZeneca said an experimental combination of lung drugs improved breathing function, potentially giving the UK firm its second chronic obstructive (...)

The acquisition is the latest in a spate of big pharma deals this year as many companies are strengthening their portfolios as old drugs go generic

AbbVie is to buy Pharmacyclics for about $21 billion, giving it access to what is expected to be one of the world’s top-selling cancer drugs and expan(...)

GSK is forming a consumer health joint venture with Novartis, while at the same time buying the Swiss company’s vaccines business and divesting its cancer drugs portfolio to Novartis

GlaxoSmithKline and Novartis said on Monday they had completed a series of asset swaps worth more than $20 billion that will reshape both drugmakers.G(...)

Pfizer has offered $90 per share in cash for Hospira Photograph: Reuters

Pharmaceutical giant Pfizer has offered to buy Hospira for about $15 billion (€13bn) to boost its portfolio of generic injectible drugs and biosimilar(...)

Joe Kaeser, chief executive of German industrial group Siemens, addresses a news conference ahead of the annual shareholder meeting in Munich on Tuesday. Siemens missed first-quarter profit forecasts and announced management overhauls at its power and gas and healthcare divisions. (Photograph: Michael Dalder/Reuters)

US equity-index futures fell with European stocks as results by companies from Caterpillar to Microsoft and Siemens disappointed investors. Greek bon(...)

Dublin index heavyweight CRH added 1.17 per cent to close at €19.83

European markets rose as oil company gains helped to counterbalance a sharp fall in Swiss equities sparked by the country’s national bank decision to(...)